After years with few advancements, five new agents were approved to treat bladder cancer within the last year. CURE spoke with Terence Friedlander, M.D. about the shifting treatment paradigm for ...

A new drug developed at UC Davis Health could provide a safer and more effective option for bladder cancer patients, reducing chemotherapy toxicity and potentially limiting the need for bladder ...

Underactive bladder syndrome is a condition that leaves sufferers with an inability to properly empty the organ due to weakened muscles, but an international team of researchers has been working on an ...

Patients with muscle-invasive bladder cancer experienced safe medical and surgical treatment with the NURE-combo. Opdivo (nivolumab) with Abraxane (nab-paclitaxel) could expand the therapeutic ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. A Kansas City-based biotechnology company has expanded a ...

A Kansas City-based biotechnology company has expanded a clinical trial for an anti-cancer drug that could potentially transform the treatment of early- and late-stage bladder cancer. CicloMed LLC has ...